The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad”…
Drug arrives years after pandemic’s peak, but could still offer critical protection to vulnerable populations. Drug arrives years after pandemic’s peak, but could still offer critical protection to vulnerable populations.
A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health.…
